Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

House Commerce Health Panel May See Many New Faces In 2013

Executive Summary

Of the two House committees with health care oversight, Energy and Commerce has more members planning departures, with expected changes especially affecting the Democratic side of the Health Subcommittee. Only a handful of Ways and Means Committee legislators are already known to be leaving.

You may also be interested in...



Senate Elections 2012: Former HHS Chief Thompson Could Return To Washington As Senator

Polls show Tommy Thompson, HHS secretary from 2001 to 2005, leading in the Wisconsin Senate race. His experience in health care could make him a fit for the Finance Committee or the Health, Education, Labor and Pensions Committee. Few members of HELP are planning to leave at the end of the session, but a number of retirements on Finance could leave space for newcomers.

GSK's Nucala Is Significantly Overpriced, ICER Draft Report Finds

New biologic for severe asthma doesn't stack up well to standard of care on generally accepted levels of cost per quality-adjusted life year.

Deal Watch: Sanofi, Boehringer Swap Side Businesses

Busy week for AstraZeneca sees buyout of Acerta and acquisition of remaining Daliresp/Daxas worldwide rights from Takeda. Amgen and GSK undo their cancer drug alliances from 2009 and 2010, with all rights reverting to the big biotech.

Topics

UsernamePublicRestriction

Register

PS054740

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel